Overweight: Clinical Trials

66 trials for Overweight, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

66 unknown. 66 Phase 2, 17 Phase 3, 10 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 266Unknown 66
Phase 317Unknown 17
Phase 110Unknown 10

Follow Overweight: new trials by email Literature Review of Overweight trials Research Report on Overweight

Trials (filtered) newest first · largest first

All 66 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Efficacy and Safety of MDR-001 in Subjects Who Are Obesity or Overweight
MDR-001, Placebo - Obesity, Overweight and Obesity
Phase 2UnknownMindRank AI Ltd3002024-09-232024-09-24
Evaluate the Safety and Efficacy of HDM1002 Tablets in Overweight and Obese Adults
HDM1002 100 mg QD, HDM1002 200 mg QD 12weeks, HDM1002 400 mg QD 12weeks - Overweight and Obesity
Phase 2UnknownHangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.1802024-07-152024-07-15
Mechanisms of Semaglutide Therapy in Heart Failure Patients
Semaglutide - Heart Failure, Obesity
Phase 1 / Phase 2UnknownUniversity Medical Centre Ljubljana102024-07-102024-08-07
Nutritional Therapy in Late-onset Pompe Disease
Multi-ingredient supplement (PDT-MIS), Placebo (PLA) - Pompe Disease, Muscle Loss
Phase 2UnknownMcMaster University282024-04-012023-11-14
Safety and Efficacy of Human Microbiota Transplantation for Overweight and Obese Type 2 Diabetes Mellitus
Fecal microbiota transplant (FMT), normal saline and glycerin/food coloring - Type 2 Diabetes Mellitus, Overweight and Obesity
Phase 2UnknownZhujiang Hospital392024-03-012024-03-15
HRS9531 Controls Weight Regain in Obese Subjects
HRS9531, HRS9531 placebo - Obesity
Phase 2UnknownShanghai Zhongshan Hospital722024-01-012024-03-01
The Effect of Addition of Metformin In Obese Non- Diabetic Patients With Heart Failure With Preserved Ejection Fraction
Metformin - Diastolic Dysfunction, Obesity
Phase 2UnknownSara ElAdawy802023-10-012023-10-11
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
HFFS - Osteoarthritis, Knee, Obesity
Phase 1 / Phase 2UnknownUniversity of Southern Mississippi242023-07-012023-08-18
Laparoscopic Guided Peri-wound Transversus Abdominis Plane Block With Bupivacaine Versus Local Wound Infiltration on Post-op Opioid Use in Laparoscopic Sleeve Gastrectomy
peri-wound Transversus Abdominis Plane Block, Local wound infiltration - Morbid Obesity, Laparoscopic Sleeve Gastrectomy
Phase 2 / Phase 3UnknownKhon Kaen University982023-04-292024-05-01
The Effects of the GOLO for Life® Plan With Release Supplement on Glycemic Control and Weight in Overweight and Obese Adults With Prediabetes or Type 2 Diabetes
Release - Type 2 Diabetes, Obese
Phase 2UnknownGolo1002023-04-202024-07-26
Study Exploring the Supportive Effect of Acarbose in Weight Management
EMP16-120/40, MR orlistat 120 mg, Conventional orlistat 120 mg, - Overweight or Obesity
Phase 2UnknownEmpros Pharma AB3202023-04-182024-02-20
Probiotic Blend in Reducing Anthropometric Measurements in Obese Adults
Probiotic blend, Placebo - Obesity, Obesity; Endocrine
Phase 2UnknownUniversidade do Extremo Sul Catarinense - Unidade Academica de Ciecias da Saude1082023-01-112023-02-21
The GATE Study: Endoscopic Sutured Gastroplasty in Type 2 Diabetic, Obese Patients Using the Endomina Device
Endoscopic sutured gastroplasty with endomina - Diabete Type 2, Obesity
Phase 2UnknownRadboud University Medical Center402022-12-012022-10-31
A Study of TG103 Injection in Overweight or Obesity
TG103 15 mg, TG103 22.5 mg, Placebo - Overweight or Obesity
Phase 2UnknownCSPC Baike (Shandong) Biopharmaceutical Co., Ltd.1952022-05-202022-05-23
Thymol on Netrin-1 on Obese Patients
Thymol - Inflammatory Response, Obesity
Phase 2UnknownCentro Universitario de Ciencias de la Salud, Mexico302022-04-012022-06-22
Effect of Akkermansia Muciniphila WST01 Strain in Overweight or Obese Patients With Type 2 Diabetes
WST01 strain product, placebo powder - Obese, Overweight
Phase 2UnknownShanghai Jiao Tong University School of Medicine602021-07-152023-10-17
Naldebain for Pain Control After Bariatric Surgery
Dinalbuphine sebacate, Placebo solution - Pain, Postoperative, Pain, Chronic
Phase 2 / Phase 3UnknownE-DA Hospital602021-06-242021-12-28
Randomized Study Comparing Metabolic Surgery With Intensive Medical Therapy to Treat Diabetic Kidney Disease
Roux-en-Y gastric bypass, Best medical treatment - Diabetes Mellitus, Type 2, Kidney Disease, Chronic
Phase 2UnknownHospital Alemão Oswaldo Cruz602021-05-252021-05-28
The Effect of SHR20004(Noiiglutide ) on Body Weight in Obese Subjects Without Diabetes
SHR20004, placebo - Obesity
Phase 2UnknownJiangsu HengRui Medicine Co., Ltd.2542021-03-292022-03-15
Efficacy and Tolerance of Liraglutide for Weight Loss in Obese Type 2 Diabetic Hemodialysis Patients
Liraglutide - Diabetes Mellitus, Type 2, Hemodialysis
Phase 2UnknownFondation Hôpital Saint-Joseph182021-01-182023-04-14

Showing 20 of 66. Sign in to see all of them.

Narrower conditions

Obesity (54)  ·  Diabetes Mellitus, Type 2 (11)  ·  Obesity, Morbid (9)  ·  Weight Loss (9)  ·  Diabetes Mellitus (4)  ·  Pediatric Obesity (3)  ·  Atherosclerosis (2)  ·  Dyslipidemias (2)  ·  Hypertension (2)  ·  Insulin Resistance (2)  ·  Metabolic Syndrome (2)  ·  Body Weight (1)  ·  Body Weight Changes (1)  ·  COVID-19 (1)

Broader conditions

Nutrition Disorders (66)  ·  Nutritional and Metabolic Diseases (66)  ·  Overnutrition (66)  ·  Pathological Conditions, Signs and Symptoms (65)  ·  Signs and Symptoms (65)  ·  Body Weight (64)  ·  Metabolic Diseases (16)  ·  Glucose Metabolism Disorders (14)  ·  Endocrine System Diseases (13)  ·  Body Weight Changes (10)  ·  Obesity (10)  ·  Diabetes Mellitus (9)  ·  Cardiovascular Diseases (6)  ·  Vascular Diseases (5)

Interventions

Metformin (3)  ·  Botulinum Toxins, Type A (2)  ·  Diet (2)  ·  Fecal Microbiota Transplantation (2)  ·  Orlistat (2)  ·  Saline Solution (2)  ·  oleoyl-estrone (2)  ·  Alprostadil (1)  ·  Butyrates (1)  ·  Capsaicin (1)  ·  Carnitine (1)  ·  Chocolate (1)  ·  Cholecalciferol (1)  ·  Diet, Carbohydrate-Restricted (1)  ·  Diet, Ketogenic (1)

Sponsors

Mansoura University (3)  ·  Manhattan Pharmaceuticals (2)  ·  University of Guadalajara (2)  ·  University of Patras (2)  ·  Advanced Specialty Care (1)  ·  Augusta University (1)  ·  Azienda Ospedaliera Universitaria Integrata Verona (1)  ·  CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. (1)  ·  Central Washington University (1)  ·  Centro Universitario de Ciencias de la Salud, Mexico (1)  ·  Charite University, Berlin, Germany (1)  ·  Colorado State University (1)  ·  E-DA Hospital (1)  ·  Empros Pharma AB (1)  ·  Essentialis, Inc. (1)

Countries

United States (13)  ·  China (7)  ·  Mexico (5)  ·  Brazil (4)  ·  Egypt (4)  ·  Israel (3)  ·  Canada (2)  ·  France (2)  ·  Germany (2)  ·  Greece (2)  ·  Italy (2)  ·  Singapore (2)  ·  South Korea (2)  ·  Spain (2)  ·  Australia (1)

Top investigators

Adaliene VM Ferreira, PhD (1)  ·  Antonio Peralta, MD (1)  ·  Asnat Walfisch, MD (1)  ·  Athena Siampalioti, M.D. (1)  ·  Athina Siampalioth, MD (1)  ·  Chen-Fuh Lam, MD, PhD (1)  ·  Claudio Maffeis, MD (1)  ·  Darrell M Wilson, MD (1)  ·  David Crowley, MD (1)  ·  Debra Haire-Joshu, PhD (1)  ·  Dirk Vissers (1)  ·  Dov Gal (1)

Results publications

PMID 11238785, PMID 11304102, PMID 11565517, PMID 11565518, PMID 11832527, PMID 12684357, PMID 15273542, PMID 15380496, PMID 15632335, PMID 16120818, PMID 16188903, PMID 18430778, PMID 18435772, PMID 18701613, PMID 18931095, PMID 19420913, PMID 19640956, PMID 19808241, PMID 19853906, PMID 19926371, PMID 19954692, PMID 20124139, PMID 20150934, PMID 20700413, PMID 20847735, PMID 20876408, PMID 21464376, PMID 21602457, PMID 21693741, PMID 21931075, PMID 21997144, PMID 22187472, PMID 22302620, PMID 22383694, PMID 22723580, PMID 22933432, PMID 23288372, PMID 23362314, PMID 24149519, PMID 24222017, PMID 24356416, PMID 24472122, PMID 24742478, PMID 24911038, PMID 25352176, PMID 25405560, PMID 25526642, PMID 26084343, PMID 26283739, PMID 26369473

NIH funding

R21DK084527 (1)